Skip to main content

Fresenius has successfully completed the divestment of fertility services group Eugin. As announced in November 2023, global fertility group IVI RMA (a KKR portfolio company) and GED Capital acquired Eugin for up to €500 million including earn-outs. The transaction has received all regulatory approvals. 

The divestment marks another milestone in the implementation of #FutureFresenius and is in line with the company’s commitment to a simplified structure, sharper focus and accelerated performance. Furthermore, the sale proceeds will benefit Fresenius’ financial flexibility.

The sale only comprises the Eugin Group. Fresenius Helios' well-established legacy business of fertility treatments in selected hospitals and outpatient centers of Quirónsalud and Helios Germany will remain with Fresenius Helios and continue to offer fertility treatments.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing and unforeseen impacts of international conflicts. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

February 26

February 26, 2024
Frankfurt, Germany

Roadshow Frankfurt

February 22

February 22, 2024
London, UK

Roadshow London

Fresenius Kabi announced today the immediate availability in the U.S. of Posaconazole Injection, a generic substitute for Noxafil®*, for the treatment or prevention of serious fungal infections. It is the newest addition to the company’s portfolio of more than 30 anti-infective molecules.

For more information, please see the website of Fresenius Kabi.


*Noxafil® is a registered trademark of Merck Sharp & Dohme LLC.
 

Fresenius Kabi announced today the immediate availability in the U.S. of Posaconazole Injection, a generic substitute for Noxafil®*, for the treatment or prevention of serious fungal infections. It is the newest addition to the company’s portfolio of more than 30 anti-infective molecules.

For more information, please see the website of Fresenius Kabi.


*Noxafil® is a registered trademark of Merck Sharp & Dohme LLC.
 

Daniela Eyrich
Team Assistant Governmental Affairs & Public Policy
T: +49 (0) 6172 608-2302
daniela.eyrich@fresenius.com

Many of us make New Year’s resolutions. And many of these resolutions focus on health, more fitness, and a more balanced diet. How about giving a vegan or low-meat diet a try? In an interview with Fresenius editor Brigitte Baas, two-Michelin-star chef Hendrik Otto from Helios and ecotrophologist Verena Kaiser explain the health benefits a vegan or low-meat diet can bring for each and every one of us. And why such a diet is also important and good for the environment.  This also applies to the Helios hospitals, where this special form of nutrition has been increasingly used for some time. 

Hendrik Otto has been responsible for sustainable cuisine and quality at Helios since 2022. Together with Verena Kaiser and the Helios catering team, he improves the food in the Helios hospitals on a sustainable basis and makes sure that the six million lunches served each year also taste good to patients.

Every now and then it's good to rethink your eating habits and change them, if necessary, especially in the New Year. One option is to eat a vegan diet. Where do you see the health aspects of such a diet?

Hendrik Otto: This diet is rich in vegetables, legumes, nuts, and fruits, and thus often also high in fiber, protein, antioxidants, and many other important nutrients. All of this is beneficial in terms of fitness, resilience, and health.  

What does this mean in concrete terms?

Verena Kaiser: Studies show that a healthy and balanced plant-based diet can reduce the risk of heart disease, certain cancers, and type 2 diabetes. It can also help to control weight and improve general health. And it is usually quick and easy to prepare, not to mention very tasty.

That does sound promising. To what extent can a vegan diet also contribute to sustainability?

Hendrik Otto: Eating a vegan diet definitely has a positive impact on the environment. Animal products often require large quantities of water, land, and feed during the production process. By eschewing animal products and eating more regional and seasonal foods, we can reduce our environmental footprint, cut greenhouse gas emissions, conserve natural resources, and save energy or transport costs.
 

"At Helios, we endeavor to meet the diverse needs of our patients". Two-Michelin-star chef Hendrik Otto has been responsible for sustainable cuisine and quality at Helios since 2022. © Janett Kartelmeyer | Helios

But how does this all work in practice in the hospital? Is vegan cuisine even possible in a commercial kitchen?

Hendrik Otto: Without a doubt! At Helios, we endeavor to meet the diverse needs of our patients. This also includes catering for special dietary needs, such as vegan food, low-meat and completely meat-free options, and regional products. Last fall, we added more than 20 new dishes to the Helios lunch menus. Whether chickpea curry with rice, falafel balls with pea puree, or a bratwurst made from 75 percent vegetable protein and just 25 percent organic pork – there is considerable variety, and we also offer them in our hospitals.

Verena Kaiser: The nutritional perspective is very important to us here. It enables us to ensure that the nutrition we are providing is balanced and delivers the necessary nutrients that are essential for the recovery and well-being of our patients. In our standard selection there are six vegetarian and four vegan dishes. 


Incidentally, a wider range of low-meat dishes is served not only at the patient’s bedside, but also in our cafeterias. There is already a daily vegan option for patients, visitors, and also our employees at many Helios locations. So, it is worth leaving old habits behind more often in the new year and trying a delicious vegan dish instead.
 

 

 

"Eating a vegan diet definitely has a positive impact on the environment"

ⓘ  What exactly is Veganuary and what does the vegan diet typically involve?

The so-called Veganuary annual challenge – a campaign that revolves around the vegan diet – traditionally takes place every January. The idea behind Veganuary is to encourage consumers to try a purely plant-based diet for a month and embrace the benefits of this diet – in order to lead a more conscious life in general. January is traditionally the month when people all over the world make New Year’s resolutions, it is therefore a good time to rethink old habits and try something new. According to experts, a vegan diet is one of the best ways to protect the environment, prevent animal suffering, stop climate change, and improve the health of millions of people.  “Veganuary” is a portmanteau word coined from  the words “vegan” and “January.”


 A vegan diet – what exactly does that mean?
During Veganuary, all foods of animal origin – such as meat, fish, poultry, dairy products, eggs, and even honey – should be avoided. Instead, vegetables, legumes, nuts, and fruit should be on the menu. Some consumers also avoid other animal products, such as leather, and oppose other forms of animal exploitation, such as animal testing. Veganism is a form of nutrition and way of life with its roots in vegetarianism. 
Those who manage to put together a diverse and balanced vegan diet should exhibit no deficiency symptoms. Only vitamin B12 should be integrated into the diet via dietary supplements, since this vitamin is mainly found in animal products. Plant-based foods usually do not contain vitamin B12 unless they have been artificially fortified.

 
History of the month
The Veganuary campaign was launched in 2014 by the organization of the same name in the UK and has since spread all over the world. The organization’s aim is to raise awareness of the one-month pledge and promote veganism. In Germany, Veganuary was first advertised back in 2019. 

Kontakt

Helios Kliniken GmbH
Friedrichstr. 136
10117 Berlin
Deutschland
T +49 30 521 321-0

www.helios-international.com
  • Fresenius drives forward the vision of Health Equity with signature.
  • The company offers broad access to healthcare and affordable versions of high-quality medicines: Every year around 24 million patients seek medical treatment at Europe’s largest hospital chain. Fresenius Kabi markets affordable and high-quality medicines worldwide. 

"Fresenius has been committed to improving the health of people worldwide for over 100 years. It is our firm belief that equal opportunity in healthcare is a moral obligation and economically beneficial for society. That is why we signed the world's most important cross-sector commitment to health equity to advance a common vision of health equity," said Michael Sen, Chief Executive Officer of Fresenius. 

Fresenius has signed the World Economic Forum's Zero Health Gaps Pledge ahead of this year's World Economic Forum in Davos. This commitment to promoting equal opportunities in healthcare is part of the Global Health Equity Network (GHEN), which brings together key players from the public and private sectors to advance a shared vision of equitable healthcare in line with the UN Sustainable Development Goals (SDGs). To date, more than 80 companies have signed the world's first voluntary commitment of this kind. By signing the pledge, Fresenius commits to acting responsibly and working together for equal opportunities in healthcare.

"With our innovations and strong partnerships, we have been enabling the delivery of high-quality, cost-effective therapies to millions of people for many years. However, fair healthcare can only be achieved as part of a consistent climate and sustainability approach. We shall strive to continuously implement this holistic approach," said Management Board member Dr. Michael Moser, who is among others responsible for Sustainability.  

Improving people's health and advancing patient care is Fresenius' corporate purpose and therefore also an important part of the company's ESG strategy. Every year around 24 million patients seek medical treatment at a Helios hospital. Fresenius markets low-cost biosimilars in around 40 countries. 

The voluntary commitment is a response to the persistent and increasing global inequalities in health between and within countries: according to the World Economic Forum's pledge, the gap in life expectancy between Japan and Lesotho is 30 years. In the USA, the gap in life expectancy between black and white men is five years on average. The global climate crisis and health crises such as the Covid-19 pandemic have exacerbated these inequalities and the potential consequences of inaction. 

The global, cross-sector pledge includes ten commitments to advance the shared vision of health equity. In this vision, all people have a fair and equitable opportunity to fulfill their human potential in all aspects of health and well-being.

Click here to read the full Zero Health Gaps Pledge with its ten key commitments and here to learn more about the Global Health Equity Network.
 

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing and unforeseen impacts of international conflicts. 
Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius has signed the World Economic Forum's Zero Health Gaps Pledge ahead of this year's World Economic Forum in Davos. This commitment to promoting equal opportunities in healthcare is part of the Global Health Equity Network (GHEN) to advance a shared vision of equitable healthcare in line with the UN Sustainable Development Goals (SDGs).

Improving people's health and advancing patient care is Fresenius' corporate purpose and therefore also an important part of the company's ESG strategy.

The full press release is available in the "Media" section of the website.
 

Subscribe to